about
Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitisMolecular Architecture of DesI: A Key Enzyme in the Biosynthesis of Desosamine † , ‡Telithromycin: a novel agent for the treatment of community-acquired upper respiratory infectionsCEM-101 activity against Gram-positive organisms.Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transportImpact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.Vancomycin resistance: occurrence, mechanisms and strategies to combat it.Acquired antibiotic resistance genes: an overview.Drug discovery from natural sources.A platform for the discovery of new macrolide antibiotics.Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitroA novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.Chalcomycin biosynthesis gene cluster from Streptomyces bikiniensis: novel features of an unusual ketolide produced through expression of the chm polyketide synthase in Streptomyces fradiae.Ketolides in the treatment of community-acquired respiratory tract infections: A review.Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin.History of Antibiotics Research.Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.Bluegenics: Bioactive Natural Products of Medicinal Relevance and Approaches to Their Diversification.A brief history of antibiotics and select advances in their synthesis.The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coliNew treatment options for lower respiratory tract infections.In vitro activities of novel 2-fluoro-naphthyridine-containing ketolidesSynthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.The wobbly status of ketolides: where do we stand?Potential interaction between telithromycin and warfarin.Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis.In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program.Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives.Design, synthesis and antibacterial activity of novel ketolides bearing an aryltetrazolyl-substituted alkyl side chain.
P2860
Q24803536-F5FF7E44-F659-40ED-BE29-82B19FA60403Q27646687-7771ABAD-364F-4C6A-A80B-7048C2DD4215Q33945038-50176046-A1E9-452F-9ABC-327597F41B47Q34100146-29C9C441-32B8-41EA-AD00-159DBD907697Q34281970-3C8602EB-A8F2-4641-AF97-784D21307F86Q34301527-C06E4267-D026-4DB5-9C4C-3738B34166D9Q34335695-79A183FF-712F-4B86-9659-735652AB5252Q35143886-96830287-BC78-423A-B188-B793AF4DC6ADQ35451219-1617E3C6-279D-480D-9762-AC0398822901Q35594873-7D27A5CC-F37D-45A6-8D17-5DCE1964FD79Q36021739-EDFC6029-2775-4342-A91C-650C1D688AB7Q36022938-3FF9B09A-49ED-4B94-9AA4-D00AA151AF7DQ36156072-5CDFDED6-1AFC-4C81-A0F8-F7C539C5DA58Q37026706-07F8BF09-4EE8-41BB-86B1-7D8EEEB833CCQ37119314-0C1D27C8-5211-41AB-A4B2-63E1E0139371Q37144788-FF987F1C-B70F-4E51-9FC4-1D06EBE819FCQ37624538-D61C4915-52E2-45EB-98DF-7A295E3C828DQ38199663-1CB6873E-1293-49EA-9E7E-5331E156065DQ38804355-CA9C75F2-A67C-4F48-825A-AD02576C2CAFQ38980021-1E7E801C-D645-48A9-AE88-C98BDB0B5D1FQ39026738-1A8A9C5A-BDDC-4484-A203-991F07735699Q39151177-A1CDC6BA-E1A7-4E43-AF41-89471148B568Q39414195-6E6F9F4A-BEF5-4D4F-9AE4-56AA5E3257CCQ39955443-493BC45F-C402-4FA1-9420-47B415C6584DQ40111519-FE09E12E-98C8-401A-9A5B-BA1DDA8E6308Q40733036-1330BE62-0E8D-4831-A459-6F4908B898C3Q43243028-044DFD82-9C62-4919-B9A4-BC7215BEF62EQ43408523-B013D442-4DC4-487D-A701-5157C5FA6DC7Q44997758-C630B96E-1138-4C25-A7D7-49FBCECE29C2Q45057564-7D66440F-0F80-425A-9410-6443853DB672Q53723800-62E8ADBD-3B95-4B1C-9726-C781EBEF74E5Q53788482-8EBD8A01-A43D-4C4E-B2D5-0942EC6692E5Q54356764-AD1279A3-4CB0-46D1-A38B-2F1D2885DDA3
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The ketolides: a critical review.
@ast
The ketolides: a critical review.
@en
The ketolides: a critical review.
@nl
type
label
The ketolides: a critical review.
@ast
The ketolides: a critical review.
@en
The ketolides: a critical review.
@nl
prefLabel
The ketolides: a critical review.
@ast
The ketolides: a critical review.
@en
The ketolides: a critical review.
@nl
P2093
P1433
P1476
The ketolides: a critical review.
@en
P2093
Aleksandra Wierzbowski
Alfred S Gin
Ayman Noreddin
Daryl J Hoban
John M Embil
Lavern M Vercaigne
Michael Walters
P304
P356
10.2165/00003495-200262120-00006
P577
2002-01-01T00:00:00Z
P6179
1033713564